Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689589017 | Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689590014 | Cyclophosphamide (as cyclophosphamide monohydrate) 200 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Product containing only cyclophosphamide in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | cyclophosphamide | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Cyclophosphamide-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a pour principe actif (attribut) | Cyclophosphamide (substance) | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a une forme pharmaceutique (attribut) | Powder for infusion solution | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a une forme pharmaceutique (attribut) | Powder for solution for injection | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Cyclophosphamide monohydrate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value (attribute) | 200 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Cyclophosphamide (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR